LoadingLoadingLoadingNet selling: insiders sold $117.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (3)
D.E. Shaw
$119.8M
added
Alger
$52.9M
added
Bank of America
$67.2M
added
Trader 75CShort
$3K
position
Trader 5B7Long
$3K
position
Trader 867Short
$671
position
Last report
Aug 3, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.50 expected
Estimates as of Oct 21, 2026
EPS expected
-$0.38 to -$0.02
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | -$0.56 / -$0.50Alpha Vantage | -12.00% miss | $118.4M No estimateSEC filing | Unavailable |
| Mar 31, 2026 | May 4, 2026 | -$0.60 / -$0.53Alpha Vantage | -13.21% miss | $110.7M No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 2, 2026 | -$0.50 / -$0.52Alpha Vantage | +3.85% beat | $103.7M No estimateSEC filing | Unavailable |
| Sep 30, 2025 | Nov 14, 2025 | -$0.45 / -$0.50Alpha Vantage | +10.00% beat | $99.0M No estimate | Unavailable |
| Jun 30, 2025 | Aug 4, 2025 | -$0.47 / -$0.57Alpha Vantage | +17.54% beat | $96.1M No estimateSEC filing | Unavailable |
| Mar 31, 2025 | May 5, 2025 | -$0.66 / -$0.56Alpha Vantage | -17.86% miss | $92.8M No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 3, 2025 | -$0.53 / -$0.63Alpha Vantage | +15.87% beat | $88.7M No estimateSEC filing | Unavailable |
| Sep 30, 2024 | Nov 18, 2024 | -$0.59 / -$0.69Alpha Vantage | +14.49% beat | $84.7M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $99.0M | $103.7M | $110.7M | $118.4M |
| Cost of what it sold | $48.2M | $49.7M | $53.6M | $55.9M |
| Gross profit | $50.8M | $54.0M | $57.1M | $62.5M |
| What it spent | ||||
| Research and development | $17.0M | $17.1M | $19.7M | $18.0M |
| Sales and admin | $56.8M | $69.9M | $76.1M | $80.7M |
| Other operating costs | $7.0M | — | — | — |
| Total operating expenses | $80.8M | $86.9M | $95.8M | $98.7M |
| What was left | ||||
| Operating profit | -$29.9M | -$32.9M | -$38.7M | -$36.3M |
| Profit before tax | -$26.9M | -$30.3M | -$44.0M | -$34.7M |
| Tax | $256.0K | $253.0K | $43.0K | -$311.0K |
| Net profit | -$27.1M | -$30.5M | -$44.0M | -$35.1M |
| EBITDA | -$20.9M | -$26.7M | -$32.2M | -$28.0M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
Form 144 Twist Bioscience Corp For: 17 October By Investing.com
NeutralOct 18Twist Bioscience Corporation (TWST) Options Chain - Yahoo Finance
Leans bearishOct 17Twist Bioscience Corporation (TWST) Stock Price, News, Quote & History
Leans bearishOct 16Technical Analysis of Twist Bioscience Corporation (CRYPTOCOM:TWSTUSD.P)
NeutralOct 15TD Cowen raises target for Twist Bioscience stock to USD 190.00
BullishOct 15Twist Bioscience CFO Laponis disposes of $384,822 in shares
NeutralOct 14Price-Driven Insight from (TWST) for Rule-Based Strategy
NeutralOct 14Form 4 Twist Bioscience Corp: Adam Laponis (CFO) For: 9 October
NeutralOct 13
